[1]
“Rethinking tuberculosis: Microbiological and immunological crossroads in the post-pandemic era”, Rev Alerg Mex, vol. 73, no. 1, pp. 109–110, Mar. 2026, doi: 10.29262/ram.v73i1.1561.